Testing effectiveness (Phase 2)WithdrawnNCT03203616
What this trial is testing
Kadcyla In pAtients With bRAin Metastasis
Who this might be right for
Metastatic HER2-positive Breast Cancer With Brain Metastasis
Jules Bordet Institute
Showing 20 of 0 results